The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
about
Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton"Diabodies": small bivalent and bispecific antibody fragmentsSelective expression of an interleukin-12 receptor component by human T helper 1 cellsBiological response modifiers in cancerProtocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.Spatial differences in active caspase-8 defines its role in T-cell activation versus cell deathEffects of intracellular calcium and actin cytoskeleton on TCR mobility measured by fluorescence recovery.Therapeutic strategies targeting proteins that regulate folate and reduced folate transport.Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cellsA small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.New approaches to antibody therapy.Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cellsCell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogeneEnhanced antigen immunogenicity induced by bispecific antibodies.Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production.Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell.Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells.Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activationActivated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells.CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT miceCharacterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules.L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity.How many ways can a killer cell kill?Non-antigen-specific triggering signals for human cytotoxic T lymphocytes.Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016).Targeting of cytotoxic cells with heterocrosslinked antibodies.A novel recombinant bispecific single-chain antibody, bscWue-1 x CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells.Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy.Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells.Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cellsEffect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice.Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation.Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.Identification of a committed T cell precursor population in adult human peripheral blood.Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton.PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation.Elimination of large tumors in mice by mRNA-encoded bispecific antibodies.
P2860
Q22253423-8CD261E9-3751-4122-AD49-4BBA871D5043Q24562167-CFD62244-136F-481D-B9CB-448F6C6CBF6DQ24670175-00B3CC5B-9185-4FF2-BDC0-2CBD47702471Q24685049-5009B446-7028-4232-B0DE-A9D842075469Q33183860-EDF3C524-8D38-498C-9024-455C31B6EA9DQ33350789-9853E9A2-F2CA-4BA6-A2E7-88953A84E364Q33392668-878E42D0-BD10-46E5-ABD8-A740D300C142Q33541483-FFFC0F23-09F8-431E-AED9-6CE32F484A2CQ33656364-42D17919-9399-40D2-8FD7-2C7423C7AA18Q34096268-ED402010-FC51-4F2A-BC1B-BEEE647EC3C5Q34130569-F443D8FC-6824-42F6-A05B-8989F83F9329Q34517676-3D83A617-3F0F-4E20-AC48-C3FE3DE97517Q34643044-41FE6D98-7A1E-47A9-AD93-EBFB2618548EQ35822603-926C1BBF-8D7F-4D98-8083-A713DF210BDBQ36230784-B4FB6004-0DDE-49D3-B50E-AC54300D0AA0Q36351292-02EE4EF5-1118-4A3C-A935-28006850BE91Q36356520-31BCDF85-2C9E-4AE9-8622-0BBAEF776AC1Q36356552-C0207C3D-B99F-4CA8-A424-2FE12AF887EAQ36361082-81E4FB9F-D35C-46B5-9D74-A8CFD949006EQ36361516-BC1B0906-C097-4E67-93DE-F30E1ACEB672Q36401500-E6BE184F-DDF9-41B7-A111-254B197FFD6EQ36777155-37E49A43-8AA3-45D2-B5BB-9C3562B5F8B6Q36821083-23DB1B45-4EDA-4151-BB1B-D758FF4553E3Q36897392-E5344216-670C-4504-BC45-5D0697E20706Q37359052-AD6B3562-4CF2-461E-9409-71CFB7EC0C3DQ38214438-18488EE9-CD63-4A07-9E91-F0978B09AC44Q38263240-BBD59553-396B-4FD4-A686-AF18B4058C80Q38903356-E869AB20-B4E5-44E2-96EC-87A53D700712Q39639738-978F20D0-A370-4857-92D8-CD1E581E7C8AQ40596850-060F1E8D-E9F4-4731-8BE4-6F5FE4AE5BB8Q40963463-CF2EDE11-8BA2-4797-9889-042905074C5CQ40970901-2B9951FE-87FC-4C98-A555-C2716C7F81F9Q41083247-89A5B48E-E596-41A7-81F2-5095811E5AFFQ41505458-644A982A-D1C2-4305-94C1-5B1BD028976AQ41548374-4175C5C8-129C-42C3-8547-1134221954F6Q42065004-19B5EEDA-67B6-41A9-A2D5-C9C56A8F8DFAQ42115047-83577E4B-89D0-480D-A84C-E954C9FB0A05Q42942785-771FCCB7-E4DB-4CCC-A14A-095073AB3656Q46158421-ACF1529D-AFCC-4240-9934-05CA33E1E71EQ50949304-2633C4D1-EBAE-4760-9EBA-4046E53B30B2
P2860
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
@en
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
@nl
type
label
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
@en
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
@nl
prefLabel
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
@en
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
@nl
P356
P1476
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
@en
P2093
Lanzavecchia A
Scheidegger D
P304
P356
10.1002/EJI.1830170118
P407
P577
1987-01-01T00:00:00Z